Sowell Financial Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,512
Closed -$31K 686
2021
Q1
$31K Buy
2,512
+1,057
+73% +$15.3K ﹤0.01% 1851
2020
Q4
$20K Buy
1,455
+681
+88% +$9.91K ﹤0.01% 1734
2020
Q3
$11K Sell
774
-240
-24% -$3.48K ﹤0.01% 1770
2020
Q2
$16K Buy
1,014
+374
+58% +$5.99K ﹤0.01% 1524
2020
Q1
$9K Hold
640
﹤0.01% 1620
2019
Q4
$13K Buy
+640
New +$5.89K ﹤0.01% 1585

Other funds holding AUPH

Sowell Financial Services's AUPH Position: Q2 2021 in Review

Sowell Financial Services sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2021, closing a stake of 2,512 shares — an estimated $31K sold.

Sowell Financial Services first reported a position in AUPH in Q4 2019 and held it in 6 quarters. The position peaked at $31K in Q1 2021. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2021.

  • Sowell Financial Services reported no remaining Aurinia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,512 Aurinia Pharmaceuticals shares in Q2 2021, an estimated $31K.
  • Sowell Financial Services first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • Sowell Financial Services's Aurinia Pharmaceuticals position peaked at $31K in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.